The stock of Aurora Cannabis Inc. (NASDAQ:ACB) decreased by -$0.01 on Wednesday to $0.51, down -3.04 percent. The last five days have seen an average of 2,503,356 shares of common stock traded. 7 times new highs were reached in the current year, with a fall of -$0.4116. The average number of shares traded over the last 20 days was 4,786,054, while the average volume over the last 50 days totaled 4,077,313.
ACB stock dropped -3.59% since last month. On 07/26/23, the company’s shares reached a one-month low of $0.4820. The stock touched a high of $1.93 on 02/02/23, after rallying from a low of $0.48 in 52 weeks. The price of ACB stock has declined by -45.04% or -$0.4116 this year, reaching a new high 7 times. Still, the stock price is down -73.73% from the 52-week high.
Valuation Metrics
Beta for the stock is 2.55. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 1.05, the price-to-book (PB) ratio of 0.38.
Financial Health
For the three months ended March 30, Aurora Cannabis Inc.’s quick ratio was 1.60, while its current ratio was 2.30, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending March 30 is 0.16, and the total debt to equity ratio is 0.33. As far as profitability goes, gross margin for the trailing twelve months is -24.70% percent. Based on annual data, it had gross profit of $16.77 million and revenue of $174.88 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. ACB’s return on assets (ROA) during the last 12 months has been -22.90%. There was a -28.80% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was -43.50%.
Earnings Surprise
According to Aurora Cannabis Inc.’s quarterly financial report for the quarter that ended March 30. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $169.55 million, while revenues rose by 100.0% to $0.0. It was predicted that Aurora Cannabis Inc.’s quarterly earnings would be -$0.18, but it ended up being -$0.05. EBITDA was -$11.99 million for the quarter. At the end of Aurora Cannabis Inc.’s most recent quarter ended March 30, its liabilities totaled 241.18 million, while its total debt was $156.38 million.
Technical Picture
Here’s a quick look at Aurora Cannabis Inc.’s (ACB) price momentum from a technical perspective. As of 15 August, the RSI 9-day stood at 38.30%, suggesting the stock is Neutral, with a 31.25% historical volatility rate.
The stochastic %K and %D were 32.85% and 41.51% respectively, while the average true range (ATR) was 0.0272. Based on the 14-day stochastic reading of 12.22%, the RSI (14) reading is 42.51%. On the 9-day MACD Oscillator, the stock is at -0.0101, and the 14-day reading is at -0.0181.
Analyst Ratings
In its most recent analyst report, Canaccord Genuity raised its rating on Aurora Cannabis Inc. (NASDAQ: ACB) to a Hold. Prior to this, analysts firm rated the stock as a Sell. Analysts have assigned Aurora Cannabis Inc. (ACB) an Hold rating. ACB is a stock that is recommended for selling by 0 brokerage firms, while 8 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 0 others recommend it as a buy.
What is ACB’s price target for the next 12 months?
The current consensus forecast for the stock is between $0.51 and $1.12, with a median target price of $0.67. In analyzing these forecasts, the average price target given by analysts for Aurora Cannabis Inc. (ACB) is $0.74.
